Pharma-Bio Serv Inc (PBSV)

OTC Markets

Currency in USD

0.54

+0.07(+14.85%)

Closed·04/09

Fair Value

Unlock Value

Day's Range

0.54

52 wk Range

0.41

1.36

PBSV Income Statement

Assess the Pharma-Bio Serv income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the PBSV net worth.

Period Ending:

2016

31/10

2017

31/10

2018

31/10

2019

31/10

2020

31/10

2021

31/10

2022

31/10

2023

31/10

2024

31/10

2025

31/10

Total Revenues

aa.aa

20.12

19.4

16.98

9.51

Total Revenues Growth

aa.aa

-6.72%

-3.56%

-12.48%

-43.99%

-5.34%

Cost Of Revenues

aa.aa

14.76

14.52

11.91

6.99

6.09

Gross Profit

aa.aa

5.36

4.88

5.07

2.52

2.91

Gross Profit Growth

aa.aa

-19.6%

-8.93%

+3.79%

-50.34%

+15.66%

Gross Profit Margin %

aa.aa

26.65%

25.16%

29.84%

26.46%

32.33%

Other Operating Expenses, Total

aa.aa

9.21

3.71

3.95

3.8

3.55

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+107.46%	-59.77%	+6.54%	-3.68%	-6.73%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9.21	3.71	3.95	3.8	3.55
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-3.85

1.17

1.12

-1.29

-0.64

Operating Income Growth

aa.aa

-273.16%

+130.49%

-4.9%

-215.23%

+50.48%

EBIT Margin %

aa.aa

-19.16%

6.06%

6.58%

-13.54%

-7.08%

Net Interest Expenses

aa.aa

0.53

0.64

Net Interest Expenses Growth

aa.aa

+20.91%

Interest Expense, Total

aa.aa

Interest And Investment Income

aa.aa

0.53

0.64

Other Non Operating Expenses, Total

aa.aa

0.02

0.01

0.57

-0.1

EBT, Excl. Unusual Items

aa.aa

-3.83

1.19

1.69

-0.76

-0.09

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

1.96

EBT, Incl. Unusual Items

aa.aa

-1.88

1.19

1.69

-0.76

-0.09

EBT, Incl. Unusual Items Growth

aa.aa

-181.92%

+163.35%

+42%

-144.77%

+87.52%

EBT, Incl. Unusual Items Margin

aa.aa

-9.33%

6.13%

9.94%

-7.94%

-1.05%

Income Tax Expense

aa.aa

0.21

0.18

0.38

0.02

0.01

Net Income to Company

aa.aa

-2.09

1.01

1.31

-0.78

-0.1

Minority Interest

aa.aa

Net Income

aa.aa

-2.09

1.01

1.31

-0.78

-0.1

Net Income Growth

aa.aa

-201.87%

+148.18%

+30.15%

-159.35%

+87.08%

Net Income Margin %

aa.aa

-10.39%

5.19%

7.72%

-8.18%

-1.12%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-2.09

1.01

1.31

-0.78

-0.1

Basic EPS - Continuing Operations

aa.aa

-0.09

0.04

0.06

-0.03

-0

Basic EPS - Continuing Operations Growth

aa.aa

-201.77%

+148.23%

+30.33%

-159.36%

+87.07%

Diluted EPS - Continuing Operations

aa.aa

-0.09

0.04

0.06

-0.03

-0

Diluted EPS - Continuing Operations Growth

aa.aa

-202.25%

+148.09%

+30.25%

-159.65%

+87.13%

Basic Weighted Average Shares Outstanding

aa.aa

23.03

22.97

22.95

Diluted Weighted Average Shares Outstanding

aa.aa

23.16

23.03

22.97

22.96

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-3.78

1.23

1.17

-1.26

-0.58

EBITDA Growth

aa.aa

-263.55%

+132.43%

-4.94%

-208.48%

+54.3%

EBITDA Margin %

aa.aa

-18.8%

6.32%

6.87%

-13.3%

-6.42%

EBIT

aa.aa

-3.85

1.17

1.12

-1.29

-0.64

* In Millions of USD (except for per share items)

FAQ

What was Pharma-Bio Serv’s revenue at year end?

At the end of the last reported fiscal year, Pharma-Bio Serv (PBSV) recorded total revenue of 9.00 million USD.

How much revenue did Pharma-Bio Serv report in the most recent quarter?

In its most recent quarterly earnings report, Pharma-Bio Serv posted revenue of 2.70 million USD.

What was Pharma-Bio Serv’s net income for the year?

For the full year, Pharma-Bio Serv reported net income of -0.10 million USD.

How much net income did Pharma-Bio Serv post in the last quarter?

In the most recent quarter, Pharma-Bio Serv (PBSV) posted net income of 0.23 million USD.

What was Pharma-Bio Serv’s gross profit for the year?

Gross profit for the year was reported at 2.91 million USD.

How much gross profit did Pharma-Bio Serv generate last quarter?

Pharma-Bio Serv recorded gross profit of 0.90 million USD in its latest quarterly report.

What was Pharma-Bio Serv’s annual operating income?

For the full year, Pharma-Bio Serv (PBSV) reported operating income of -0.64 million USD.

What was Pharma-Bio Serv’s operating income last quarter?

Quarterly operating income was 0.14 million USD.

What was Pharma-Bio Serv’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 0.16 million USD.

What was the quarter-over-quarter change in EBITDA for Pharma-Bio Serv?

EBITDA changed by 298.54% million USD compared to the last quarter.

What is Pharma-Bio Serv’s most recent gross profit margin?

The latest reported gross profit margin for Pharma-Bio Serv (PBSV) is 33.37% million USD.

What is Pharma-Bio Serv’s most recent net income margin?

Net income margin based on recent financials is 8.62% million USD.

What is Pharma-Bio Serv’s most recent EBIT margin?

Pharma-Bio Serv reported an EBIT margin of 5.35% million USD based on current figures.

How did Pharma-Bio Serv’s revenue change compared to the previous quarter?

Revenue changed by 17.78% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Pharma-Bio Serv?

In the latest quarter, gross profit changed by 24.87% million USD from the previous quarter.

S&P/TSX

36,123.05

-390.75

-1.07%

S&P/TSX 60

2,117.92

-28.01

-1.31%

US 30

52,791.30

+3.8

+0.01%

US 500

7,681.70

+8.1

+0.10%

S&P 500 VIX

15.72

+0.42

+2.75%

DAX

26,007.63

+1.10

0.00%

Dollar Index

98.653

-0.129

-0.13%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	70.17	+0.56%	37.49M
Suncor Energy	93.71	+0.61%	14.73M
Toronto Dominion Bank	166.18	-1.22%	5.02M
Enbridge	69.69	+0.53%	10.99M
Bank of Nova Scotia	128.00	-1.27%	4.94M
RBC	288.21	-1.12%	2.13M
TC Energy	87.45	+1.06%	5.48M

Name	Last	Chg. %	Vol.
Pioneer Media Holdings	0.01	+200.00%	0.00
Lanebury Growth Capital	0.15	+200.00%	1.00K
Celestial Acquisition	0.20	+185.71%	3.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Psyched Wellness	0.01	+100.00%	2.50K
ePlay Digital	0.010	+100.00%	7.00K
LFNT Resources	0.20	+90.48%	17.50K

Name	Last	Chg. %	Vol.
Global Health Clinics	0.055	-80.00%	500.00
Spacefy	0.005	-75.00%	38.33K
Quantum Battery Metals	0.230	-53.54%	8.23K
InsuraGuest Technologies	0.0050	-50.00%	95.62K
Ramm Pharma	0.01	-50.00%	1.00K
Molecule Holdings	0.005	-50.00%	20.11K
Albert Labs International	0.005	-50.00%	1.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Bombardier Inc	307.130	-2.54%	659.77K
Celestica Inc.	454.60	+5.12%	538.06K
Keel Infra	5.13	+6.65%	5.07M
HIVE Digital Tech	4.3400	+1.64%	2.71M
TELUS	13.32	-0.52%	5.65M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaaaaaaa	32.18	+53.12%	49.27
Aaaaaaaaaaaa A	8.86	+50.99%	13.38
Aa Aaa	97.42	+46.90%	143.11
Aaaaaaaaaaa Aa	15.75	+46.41%	23.06
A A Aaaaaa Aaaaa	7.52	+44.68%	10.88
Aaaaaaaaaaa	120.24	+44.68%	173.96
Aaaa A	5.24	+43.94%	7.54

Name	Last	Upside	Fair Value
A Aaaaaaaaaa	32.18	+53.12%	49.27
Aaaaaaaaaaaa A	8.86	+50.99%	13.38
Aa Aaa	97.42	+46.90%	143.11
Aaaaaaaaaaa Aa	15.75	+46.41%	23.06
A A Aaaaaa Aaaaa	7.52	+44.68%	10.88
Aaaaaaaaaaa	120.24	+44.68%	173.96
Aaaa A	5.24	+43.94%	7.54

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Pharma-Bio Serv Inc (PBSV)

PBSV Income Statement

FAQ

What was Pharma-Bio Serv’s revenue at year end?

How much revenue did Pharma-Bio Serv report in the most recent quarter?

What was Pharma-Bio Serv’s net income for the year?

How much net income did Pharma-Bio Serv post in the last quarter?

What was Pharma-Bio Serv’s gross profit for the year?

How much gross profit did Pharma-Bio Serv generate last quarter?

What was Pharma-Bio Serv’s annual operating income?

What was Pharma-Bio Serv’s operating income last quarter?

What was Pharma-Bio Serv’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Pharma-Bio Serv?

What is Pharma-Bio Serv’s most recent gross profit margin?

What is Pharma-Bio Serv’s most recent net income margin?

What is Pharma-Bio Serv’s most recent EBIT margin?

How did Pharma-Bio Serv’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Pharma-Bio Serv?

Trending Stocks